Pathological complete response of initially unresectable multiple liver metastases achieved using combined peptide receptor radionuclide therapy and somatostatin analogs following pancreatic neuroendocrine tumor resection: a case report
Abstract Background Peptide receptor radionuclide therapy (PRRT) serves as a novel and effective treatment option for somatostatin receptor-positive unresectable liver metastases of pancreatic neuroendocrine tumors (PNETs). However, there are few reported cases of surgical resection for initially un...
Saved in:
Main Authors: | Ryosuke Umino, Satoshi Nara, Noritoshi Kobayashi, Takahiro Mizui, Takeshi Takamoto, Daisuke Ban, Minoru Esaki, Nobuyoshi Hiraoka, Kazuaki Shimada |
---|---|
Format: | Article |
Language: | English |
Published: |
Japan Surgical Society
2024-02-01
|
Series: | Surgical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40792-024-01839-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy
by: Tobias Stemann Lau, et al.
Published: (2025-06-01) -
Unmasking insulinoma following commencement of somatostatin analogues in malignant neuroendocrine tumours
by: Isuru Gamage, et al.
Published: (2025-07-01) -
Risk of bowel ischemia in patients with mesenteric neuroendocrine tumors after treatment with 177Lu-DOTATATE
by: Eleonora Pelle, et al.
Published: (2025-07-01) -
NEUROENDOCRINE TUMORS OF THE CERVIX
by: K. V. Safronova, et al.
Published: (2020-10-01) -
Mixed neuroendocrine–non-neuroendocrine neoplasm of the ampulla of Vater: a case report
by: Kenjiro Date, et al.
Published: (2023-06-01)